Walvax Biotechnology Co., Ltd. (SHE: 300142)
China flag China · Delayed Price · Currency is CNY
15.96
+0.07 (0.44%)
Nov 15, 2024, 10:22 AM CST

Walvax Biotechnology Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 2018 - 2014
Cash & Equivalents
3,6234,3653,8733,4431,9622,381
Upgrade
Cash & Short-Term Investments
3,6234,3653,8733,4431,9622,381
Upgrade
Cash Growth
-11.35%12.68%12.49%75.54%-17.62%-4.15%
Upgrade
Accounts Receivable
2,7153,1013,5772,4812,004512.84
Upgrade
Other Receivables
81.02166.15416.13774.86304.77217.19
Upgrade
Receivables
2,7963,2673,9933,2552,308730.03
Upgrade
Inventory
908.621,035995.81873.59483.56313.05
Upgrade
Other Current Assets
70.1967.2486.25107.9426.7719.41
Upgrade
Total Current Assets
7,3988,7338,9487,6804,7803,444
Upgrade
Property, Plant & Equipment
4,0053,7683,1612,6041,5901,389
Upgrade
Long-Term Investments
985.731,0571,2921,4911,605862.27
Upgrade
Goodwill
33.6633.6633.6633.6633.6633.66
Upgrade
Other Intangible Assets
1,0131,0861,167434.98271.68127.04
Upgrade
Long-Term Deferred Tax Assets
96.28103.44124.84168.01138.5591.61
Upgrade
Long-Term Deferred Charges
507.18473.48309.381,022890883.92
Upgrade
Other Long-Term Assets
965.07333.54300.2240.63329.41186.97
Upgrade
Total Assets
15,00415,58915,33613,6749,6387,018
Upgrade
Accounts Payable
1,5051,8051,8361,258607.79276.74
Upgrade
Accrued Expenses
29.82776.631,189754.71497.4145.88
Upgrade
Short-Term Debt
220.16320.2797.1831040-
Upgrade
Current Portion of Long-Term Debt
42.498.79----
Upgrade
Current Portion of Leases
-21.8823.354.6--
Upgrade
Current Income Taxes Payable
13.6314.1319.472.0368.5432.97
Upgrade
Current Unearned Revenue
43.3842.4766.7835.299.68-
Upgrade
Other Current Liabilities
535.82214.66276.22870.61198.55732.88
Upgrade
Total Current Liabilities
2,3903,2043,5093,2351,4221,088
Upgrade
Long-Term Debt
449.31434.9314.24---
Upgrade
Long-Term Leases
13.2220.627.741.06--
Upgrade
Long-Term Unearned Revenue
283.12423.33404.53344.3256.18223.14
Upgrade
Long-Term Deferred Tax Liabilities
65.0768.7190.9494.56112.2740.16
Upgrade
Other Long-Term Liabilities
73.0342.08----
Upgrade
Total Liabilities
3,2744,1944,3463,6751,7901,352
Upgrade
Common Stock
1,5991,6071,6071,6011,5461,537
Upgrade
Additional Paid-In Capital
4,5494,9004,9654,7723,2622,755
Upgrade
Retained Earnings
3,2242,9842,5801,8951,546573.19
Upgrade
Treasury Stock
--358.63-286.42---
Upgrade
Comprehensive Income & Other
217.18217.18217.18216.33190.88-
Upgrade
Total Common Equity
9,5909,3499,0848,4846,5454,865
Upgrade
Minority Interest
2,1402,0461,9061,5151,303800.8
Upgrade
Shareholders' Equity
11,73011,39510,9909,9997,8485,666
Upgrade
Total Liabilities & Equity
15,00415,58915,33613,6749,6387,018
Upgrade
Total Debt
725.17806.42462.51315.6740-
Upgrade
Net Cash (Debt)
2,8983,5583,4113,1281,9222,381
Upgrade
Net Cash Growth
-17.98%4.31%9.06%62.77%-19.30%8.32%
Upgrade
Net Cash Per Share
1.812.222.131.991.231.55
Upgrade
Filing Date Shares Outstanding
1,5991,5991,6011,6011,5461,537
Upgrade
Total Common Shares Outstanding
1,5991,5991,6011,6011,5461,537
Upgrade
Working Capital
5,0085,5295,4404,4453,3582,355
Upgrade
Book Value Per Share
6.005.855.675.304.233.16
Upgrade
Tangible Book Value
8,5438,2307,8838,0166,2394,704
Upgrade
Tangible Book Value Per Share
5.345.154.925.014.043.06
Upgrade
Buildings
-948.5767.91541.68487.84461.58
Upgrade
Machinery
-2,0931,5801,235930.76744.39
Upgrade
Construction In Progress
-1,6451,5091,527762.51699.23
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.